Novel mRNA technology-based biologic drug treatment options
2030
Bio-innovative drug combinations （mAb和mRNA）Biopharmaceutical Product Launch
2035
fully integrated multi-therapeutical area, international company eith multi biotechnology platforms
Development of bio-innovative drugs
In the next 15 years, bio-innovative drugs motivate the realization of the whole industry chain capability of large molecule biologics from stock solution to formulation.
Nanjing Headquarter
Drug development and commercialization based on mRNA technology
Cheng Du
Development and manufacturing of monoclonal antibody drugs
